HY
Hao Yin is a researcher at MIT. His work focuses on genome editing and delivery technologies, including CRISPR-Cas9 and nanoparticle-based systems for therapeutic applications. He has contributed to the development of in vivo genome editing approaches for treating genetic diseases.
- Field
- Engineering · Bioengineering
- Clarivate categories
- Cross-Field
- Affiliation
- Massachusetts Institute of Technology (MIT), United States